Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Manancial - Repositório Digital da UFSM |
dARK ID: | ark:/26339/0013000012x41 |
Texto Completo: | http://repositorio.ufsm.br/handle/1/5928 |
Resumo: | In the last decades the invasive mycoses caused by opportunistic fungi has showed a significant growth. The extensive use of azoles showed that the development of resistance of Candida species to these drugs is an emergent phenomenon. C. glabrata typically presents high degree of primary resistance to fluconazole what determine additional difficulties in the therapies. Here two groups of C. glabrata isolates were evaluated: the first formed by strains primarily fluconazole-susceptible and the second generated by the first, was composed by the same isolates after induction of the fluconazole-resistance. The susceptibility tests detected even in the first group, strains azole-resistant as against itraconazole and voriconazole. The induction of resistance to fluconazole was carried out in order to compare the susceptibilities between the two groups against combined drugs. The fluconazole-resistant strains (Group 2) showed MIC ≥ 64 μg/ml and cross-resistance was either detected with fluconazole, voriconazole and itraconazole as well as to other antifungal agents as amphotericin B and caspofungine. The more frequent interaction observed was indifference, however important synergisms were showed against fluconazole-resistant isolates. The best synergism was registered with amphotericin B+ flucytosine (G1 = 61,77% and G2=76,47%). Other synergistic interactions were amphotericin B+ketoconazole (G2=73,53%), amphotericin B+voriconazole (G2=55,88%), amphotericin B+voricoonazole (G2=55,88%), all of them without antagonisms. The highest percentage of the antagonism were observed with ketoconazole+flucytosine (G1=61,77% and G2= 55,88%). |
id |
UFSM_1c8d5134657d711fdd2f8d11c8c85d57 |
---|---|
oai_identifier_str |
oai:repositorio.ufsm.br:1/5928 |
network_acronym_str |
UFSM |
network_name_str |
Manancial - Repositório Digital da UFSM |
repository_id_str |
|
spelling |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicosCandida glabrataResistênciaFluconazolAntifúngicosCandida glabrataResistanceFluconazoleAntifungalsCNPQ::CIENCIAS DA SAUDE::FARMACIAIn the last decades the invasive mycoses caused by opportunistic fungi has showed a significant growth. The extensive use of azoles showed that the development of resistance of Candida species to these drugs is an emergent phenomenon. C. glabrata typically presents high degree of primary resistance to fluconazole what determine additional difficulties in the therapies. Here two groups of C. glabrata isolates were evaluated: the first formed by strains primarily fluconazole-susceptible and the second generated by the first, was composed by the same isolates after induction of the fluconazole-resistance. The susceptibility tests detected even in the first group, strains azole-resistant as against itraconazole and voriconazole. The induction of resistance to fluconazole was carried out in order to compare the susceptibilities between the two groups against combined drugs. The fluconazole-resistant strains (Group 2) showed MIC ≥ 64 μg/ml and cross-resistance was either detected with fluconazole, voriconazole and itraconazole as well as to other antifungal agents as amphotericin B and caspofungine. The more frequent interaction observed was indifference, however important synergisms were showed against fluconazole-resistant isolates. The best synergism was registered with amphotericin B+ flucytosine (G1 = 61,77% and G2=76,47%). Other synergistic interactions were amphotericin B+ketoconazole (G2=73,53%), amphotericin B+voriconazole (G2=55,88%), amphotericin B+voricoonazole (G2=55,88%), all of them without antagonisms. The highest percentage of the antagonism were observed with ketoconazole+flucytosine (G1=61,77% and G2= 55,88%).Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorA freqüência de micoses invasivas devido a fungos oportunistas tem evidenciado significativo aumento nas duas últimas décadas. O uso prolongado e indiscriminado dos azólicos evidenciou o desenvolvimento de resistência a estes fármacos nas espécies de Candida. A espécie C. glabrata caracteriza-se por elevados percentuais de resistência primária ao fluconazol fato que determina dificuldades terapêuticas adicionais. No presente estudo, dois grupos de isolados de C. glabrata foram avaliados: o primeiro formado por isolados clínicos sensíveis ao fluconazol, e o segundo, derivado do primeiro, foi formado pelos mesmos isolados, após terem sido induzidos a resistência ao fluconazol in vitro. Mesmo neste grupo de C. glabrata sensíveis ao fluconazol, os testes de suscetibilidade já evidenciaram resistência frente a outros azólicos como ao itraconazol e voriconazol. Os derivados resistentes ao fluconazol evidenciaram concentrações inibitórias mínimas maiores ou iguais a 64 g/mL. Neste grupo de isolados fluconazol-resistentes, os testes de suscetibilidade detectaram resistência cruzada com cetoconazol, voriconazol e itraconazol bem como com outros agentes de outras classes como a anfotericina B e caspofungina. A indução da resistência foi realizada com o objetivo de se comparar a suscetibilidade entre os dois grupos, frente a fármacos combinados. As associações de antifúngicos entre os grupos sensíveis e resistentes ao fluconazol resultaram, em maior parte, interações indiferentes. No entando as associações mostraram-se mais eficazes nos isolados resistentes ao fluconazol. Em ambos os grupos, a combinação que resultou em maior sinergismo foi anfotericina B com flucitosina (.G1 = 61,77%.% e G2 = 76,47%); outras combinações sinérgicas foram anfotericina B + cetoconazol (G2 = 73,53%), anfotericina B + voriconazol (G2 = 55,88%), todos com ausência de antagonismo. Os maiores percentuais de antagonismo foram observados na combinação cetoconazol + flucitosina (G1 = 61,77% e G2 = 55,88%).Universidade Federal de Santa MariaBRFarmáciaUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasAlves, Sydney Hartzhttp://lattes.cnpq.br/0330782478769631Lübeck, Irinahttp://lattes.cnpq.br/1405850939282996Botton, Sônia de Avilahttp://lattes.cnpq.br/0814772095155945Alves, Izabel Almeida2013-05-132013-05-132011-03-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfapplication/pdfALVES, Izabel Almeida. AVALIAÇÃO DA SUSCETIBILIDADE DE Candida glabrata RESISTENTES AO FLUCONAZOL FRENTE A COMBINAÇÕES DE ANTIFÚNGICOS. 2011. 82 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2011.http://repositorio.ufsm.br/handle/1/5928ark:/26339/0013000012x41porinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2022-10-10T15:19:52Zoai:repositorio.ufsm.br:1/5928Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2022-10-10T15:19:52Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false |
dc.title.none.fl_str_mv |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos |
title |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos |
spellingShingle |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos Alves, Izabel Almeida Candida glabrata Resistência Fluconazol Antifúngicos Candida glabrata Resistance Fluconazole Antifungals CNPQ::CIENCIAS DA SAUDE::FARMACIA |
title_short |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos |
title_full |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos |
title_fullStr |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos |
title_full_unstemmed |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos |
title_sort |
Avaliação da suscetibilidade de Candida glabrata resistentes ao fluconazol frente a combinações de antifúngicos |
author |
Alves, Izabel Almeida |
author_facet |
Alves, Izabel Almeida |
author_role |
author |
dc.contributor.none.fl_str_mv |
Alves, Sydney Hartz http://lattes.cnpq.br/0330782478769631 Lübeck, Irina http://lattes.cnpq.br/1405850939282996 Botton, Sônia de Avila http://lattes.cnpq.br/0814772095155945 |
dc.contributor.author.fl_str_mv |
Alves, Izabel Almeida |
dc.subject.por.fl_str_mv |
Candida glabrata Resistência Fluconazol Antifúngicos Candida glabrata Resistance Fluconazole Antifungals CNPQ::CIENCIAS DA SAUDE::FARMACIA |
topic |
Candida glabrata Resistência Fluconazol Antifúngicos Candida glabrata Resistance Fluconazole Antifungals CNPQ::CIENCIAS DA SAUDE::FARMACIA |
description |
In the last decades the invasive mycoses caused by opportunistic fungi has showed a significant growth. The extensive use of azoles showed that the development of resistance of Candida species to these drugs is an emergent phenomenon. C. glabrata typically presents high degree of primary resistance to fluconazole what determine additional difficulties in the therapies. Here two groups of C. glabrata isolates were evaluated: the first formed by strains primarily fluconazole-susceptible and the second generated by the first, was composed by the same isolates after induction of the fluconazole-resistance. The susceptibility tests detected even in the first group, strains azole-resistant as against itraconazole and voriconazole. The induction of resistance to fluconazole was carried out in order to compare the susceptibilities between the two groups against combined drugs. The fluconazole-resistant strains (Group 2) showed MIC ≥ 64 μg/ml and cross-resistance was either detected with fluconazole, voriconazole and itraconazole as well as to other antifungal agents as amphotericin B and caspofungine. The more frequent interaction observed was indifference, however important synergisms were showed against fluconazole-resistant isolates. The best synergism was registered with amphotericin B+ flucytosine (G1 = 61,77% and G2=76,47%). Other synergistic interactions were amphotericin B+ketoconazole (G2=73,53%), amphotericin B+voriconazole (G2=55,88%), amphotericin B+voricoonazole (G2=55,88%), all of them without antagonisms. The highest percentage of the antagonism were observed with ketoconazole+flucytosine (G1=61,77% and G2= 55,88%). |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-03-25 2013-05-13 2013-05-13 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
ALVES, Izabel Almeida. AVALIAÇÃO DA SUSCETIBILIDADE DE Candida glabrata RESISTENTES AO FLUCONAZOL FRENTE A COMBINAÇÕES DE ANTIFÚNGICOS. 2011. 82 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2011. http://repositorio.ufsm.br/handle/1/5928 |
dc.identifier.dark.fl_str_mv |
ark:/26339/0013000012x41 |
identifier_str_mv |
ALVES, Izabel Almeida. AVALIAÇÃO DA SUSCETIBILIDADE DE Candida glabrata RESISTENTES AO FLUCONAZOL FRENTE A COMBINAÇÕES DE ANTIFÚNGICOS. 2011. 82 f. Dissertação (Mestrado em Farmacologia) - Universidade Federal de Santa Maria, Santa Maria, 2011. ark:/26339/0013000012x41 |
url |
http://repositorio.ufsm.br/handle/1/5928 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Santa Maria BR Farmácia UFSM Programa de Pós-Graduação em Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade Federal de Santa Maria BR Farmácia UFSM Programa de Pós-Graduação em Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
reponame:Manancial - Repositório Digital da UFSM instname:Universidade Federal de Santa Maria (UFSM) instacron:UFSM |
instname_str |
Universidade Federal de Santa Maria (UFSM) |
instacron_str |
UFSM |
institution |
UFSM |
reponame_str |
Manancial - Repositório Digital da UFSM |
collection |
Manancial - Repositório Digital da UFSM |
repository.name.fl_str_mv |
Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM) |
repository.mail.fl_str_mv |
atendimento.sib@ufsm.br||tedebc@gmail.com |
_version_ |
1815172438829301760 |